Passage of intravenous immunoglobulin and interaction with the CNS.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Journal of Neurology Neurosurgery & Psychiatry

• Publication date

  1994-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/jnnp.57.Suppl.21PMID 7964846PMCID PMC1016718
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fc receptor for IgG (FcR) on rat microglia.

  1994cited by this paper
• Safety of intravenous immunoglobulin.

  1993cited by this paper
• Early diagnosis and intravenous immune globulin therapy in paraneoplastic cerebellar degeneration.

  1993cited by this paper
• Murine tumor necrosis factor alpha is transported from blood to brain in the mouse.

  1993cited by this paper
• Intravenous high‐dose gammaglobulins for intractable childhood epilepsy

  1993cited by this paper
• Soluble CD4, CD8, and HLA molecules in commercial immunoglobulin preparations.

  1993cited by this paper
• MATTERS ARISING

  1993cited by this paper
• Absence of the amyloid precursor protein gene mutation (APP717: Val->Ile) in 85 cases of early onset Alzheimer's disease.

  1993cited by this paper
• A correlative triad of gadolinium‐DTPA MRI, EDSS, and CSF‐MBP in relapsing multiple sclerosis patients treated with high‐dose intravenous methylprednisolone

  1992cited by this paper
• Circulating antineuronal antibodies reach neurons in vivo: an autopsy study

  1992cited by this paper
• Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: a new view.

  1992cited by this paper
• A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group.

  1992cited by this paper
• Manipulating the immune system with immune globulin.

  1992cited by this paper
• Improved vision after intravenous immunoglobulin in stable demyelinating optic neuritis

  1992cited by this paper
• Open controlled therapeutic trial of intravenous immune globulin in relapsing-remitting multiple sclerosis.

  1992cited by this paper
• 99mTc human immunoglobulin scintigraphy--a reliable method to detect joint activity in rheumatoid arthritis.

  1992cited by this paper
• Use of intravenous immunoglobulin in various medical conditions. A Japanese experience

  1991cited by this paper
• Treatment of myasthenia gravis with high‐dose intravenous immunoglobulin

  1991cited by this paper
• Treatment of HTLV-I-associated myelopathy with high-dose intravenous gammaglobulin

  1991cited by this paper
• Blood-brain barrier damage in acute multiple sclerosis plaques. An immunocytological study.

  1991cited by this paper
• Purification of autoantibodies to myelin basic protein by antigen specific affinity chromatography from cerebrospinal fluid IgG of multiple sclerosis patients. Immunoreactivity studies with human myelin basic protein.

  1991cited by this paper
• Cationization of immunoglobulin G results in enhanced organ uptake of the protein after intravenous administration in rats and primate.

  1991cited by this paper
• Effect of intraventricular injection of an anti-Purkinje cell antibody (anti-Yo) in a guinea pig model.

  1991cited by this paper
• Intravenous immunoglobulins (IVIg) in the treatment of autoimmune diseases

  1991cited by this paper
• Duration and selectivity of blood-brain barrier breakdown in chronic relapsing experimental allergic encephalomyelitis studied by gadolinium-DTPA and protein markers.

  1990cited by this paper
• High‐dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy

  1990cited by this paper
• Blood brain barrier permeability in multiple sclerosis using labelled DTPA with PET, CT and MRI.

  1989cited by this paper
• MS: a CNS and systemic autoimmune disease.

  1989cited by this paper
• Isoelectric point restriction of cerebrospinal fluid and serum IgG antibodies to measles virus polypeptides in multiple sclerosis.

  1987cited by this paper
• Characterization of immunoglobulin G-Fe receptor activity in the outflow system of the cerebrospinal fluid

  1987cited by this paper
• Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the central nervous system.

  1987cited by this paper
• Intraneuronal IgG in the central nervous system

  1987cited by this paper
• Immunologic responses of progressive multiple sclerosis patients treated with an anti‐T‐cell monoclonal antibody, anti‐T12

  1986cited by this paper
• Intraneuronal IgG in the central nervous system.

  1986cited by this paper
• Selective extraction of small and large molecules from the cerebrospinal fluid by Purkinje neurons.

  1985cited by this paper
• Successful reversal of echovirus encephalitis in X-linked hypogammaglobulinemia by intraventricular administration of immunoglobulin.

  1985cited by this paper
• S‐Sulfonation: a Reversible Chemical Modification of Human Immunoglobulins Permitting Intravenous Application

  1983cited by this paper
• S‐Sulfonation: a Reversible Chemical Modification of Human Immunoglobulins Permitting Intravenous Application

  1983cited by this paper
• Study of protein characteristics that influence entry into the cerebrospinal fluid of normal mice and mice with encephalitis.

  1982cited by this paper
• [Cerebrospinal fluid passage of therapeutic immunoglobulins of the IgG class in infectious inflammatory disease of the CNS].

  1981cited by this paper
• Binding sites for immune components in human choroid plexus.

  1981cited by this paper
• [Human i.v. immune globulin by chemical modification with beta-propiolactone/radiochemical study (author's transl)].

  1980cited by this paper
• Multiple sclerosis

  1980cited by this paper
• Protein size and cerebrospinal fluid composition

  1974cited by this paper

• The Expression of Non B Cell-Derived Immunoglobulins.

  2024cites this paper
• Nano Differential Scanning Fluorimetry-Based Thermal Stability Screening and Optimal Buffer Selection for Immunoglobulin G

  2021cites this paper
• Plasma-Derived Immunoglobulins

  2019cites this paper
• Monoclonal Antibodies: From Structure to Therapeutic Application

  2019cites this paper
• Peripheral and central nervous system distribution of the CGRP neutralizing antibody [125I] galcanezumab in male rats

  2019cites this paper
• Pharmacokinetics of Bispecific Antibody

  2017cites this paper
• Intravenous Immunoglobulin to Fight Complex Regional Pain Syndrome: Is Hope Gone?

  2017cites this paper
• Dose‐dependent inhibition of demyelination and microglia activation by IVIG

  2016influential citation
• ADME for Therapeutic Biologics: Antibody‐Derived Proteins and Proteins with Novel Scaffolds

  2015cites this paper
• Clinical pharmacology of bispecific antibody constructs

  2015cites this paper
• Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria.

  2014cites this paper
• Monoclonal Antibodies: From Structure to Therapeutic Application

  2013cites this paper
• Interaction between intravenous immunoglobulin (IVIg) and the low-density lipoprotein receptor-related protein 1: a role for transcytosis across the blood brain barrier?

  2012influential citation
• Sustained levels of antibodies against Aβ in amyloid-rich regions of the CNS following intravenous dosing in human APP transgenic mice.

  2012influential citation
• Monoclonal antibodies: what are the pharmacokinetic and pharmacodynamic considerations for drug development?

  2012cites this paper
• Antibodies Preventing the Interaction of Tissue-Type Plasminogen Activator With N-Methyl-D-Aspartate Receptors Reduce Stroke Damages and Extend the Therapeutic Window of Thrombolysis

  2011cites this paper
• C2 Plasma-derived immunoglobulins

  2011cites this paper
• Gene expression patterns in the ventral tegmental area relate to oestrus behaviour in high-producing dairy cows.

  2011cites this paper
• Using B Cell Characteristics as Predictors of Multiple Sclerosis in Clinically Isolated Syndrome Patients

  2009cites this paper
• Monomeric IgG Is Neuroprotective via Enhancing Microglial Recycling Endocytosis and TNF-α

  2008cites this paper
• Expression of immunoglobulin gene with classical V-(D)-J rearrangement in mouse brain neurons.

  2008cites this paper
• Intravenous Immunoglobulins in Refractory Childhood‐Onset Epilepsy: Effects on Seizure Frequency, EEG Activity, and Cerebrospinal Fluid Cytokine Profile

  2007influential citation
• IgG entry and deposition are components of the neuroimmune response in Batten disease.

  2007cites this paper
• Epilepsy and the immune system: is there a link?

  2005cites this paper
• Intravenous immunoglobulin and multiple sclerosis

  2005cites this paper
• European study on intravenous immunoglobulin in multiple sclerosis: results of magnetization transfer magnetic resonance imaging analysis.

  2004cites this paper
• EXTRAVASATION OF BLOOD-BORNE IMMUNOGLOBULIN G THROUGH BLOOD-BRAIN BARRIER DURING ADRENALINE-INDUCED TRANSIENT HYPERTENSION IN THE RAT

  2004cites this paper
• The clinical pharmacology of therapeutic monoclonal antibodies

  2004influential citation
• IV immunoglobulins as add-on treatment to methylprednisolone for acute relapses in MS

  2004cites this paper
• Intravitreal human immune globulin in a rabbit model of Staphylococcus aureus toxin-mediated endophthalmitis: a potential adjunct in the treatment of endophthalmitis.

  2004cites this paper
• Treatment with Monoclonal Antibodies

  2004cites this paper
• Human immunoglobulin as a treatment for West Nile virus infection.

  2003cites this paper
• The role of intravenous immunoglobulin in the treatment of multiple sclerosis.

  2003cites this paper
• 7th European Charcot Foundation Lecture The role of intravenous immunoglobulin in the treatment of multiple sclerosis

  2003cites this paper
• Parvovirus B19 encephalitis presenting as immune restoration disease after highly active antiretroviral therapy for human immunodeficiency virus infection.

  2003influential citation
• IgG-immunostaining in the intact rabbit brain: variable but significant staining of hippocampal and cerebellar neurons with anti-IgG.

  2002cites this paper
• Ventajas de la gammaglobulina endovenosa en el síndrome de Guillain-Barré en el niño

  2002cites this paper
• The use of immunoglobulins in the treatment of human epilepsy

  2002cites this paper
• High-dose mouse immunoglobulin G administration suppresses Theiler's murine encephalomyelitis virus-induced demyelinating disease.

  2000cites this paper
• beta-peptide immunization: a possible new treatment for Alzheimer disease.

  2000cites this paper
• (cid:98) -Peptide Immunization A Possible New Treatment for Alzheimer Disease

  2000cites this paper
• Efficacy of donepezil in Alzheimer ’ s disease : Fact or artifact ?

  1999cites this paper
• Adverse Effects of Intravenous Immunoglobulin Therapy

  1999cites this paper
• Use of Intravenous Immunoglobulin in Multiple Sclerosis

  1998cites this paper
• Autoantibodies in neurodegenerative diseases: antigen-specific frequencies and intrathecal analysis.

  1998cites this paper
• Intracerebroventricular Passive Immunization. I. The Effect of Intracerebroventricular Administration of an Antiserum to Tumor Necrosis Factor-α on the Plasma Adrenocorticotropin Response to Lipopolysaccharide in Rats.

  1998cites this paper
• Intracerebroventricular passive immunization. I. The effect of intracerebroventricular administration of an antiserum to tumor necrosis factor-alpha on the plasma adrenocorticotropin response to lipopolysaccharide in rats.

  1998cites this paper
• Intravenous immunoglobulin treatment in multiple sclerosis Effect on relapses

  1998cites this paper
• Intravenous immunoglobulin G reduces MRI activity in relapsing multiple sclerosis

  1998cites this paper
• Intravenous immunoglobulin treatment in Multiple Sclerosis and experimental autoimmune encephalomyelitis - the Israeli Experience

  1997cites this paper
• Virus validation studies of immunoglobulin preparations.

  1996cites this paper
• Degenerative Neurological and Neuromuscular Disease Dovepress Intravenous Immunoglobulin for the Treatment of Alzheimer's Disease: Current Evidence and Considerations

  year unknowncites this paper